Tokyo Tape
Sign in
← Toho Holdings

Quarterly report · Q1

8129.TEDINET S100OXRX
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥323.4bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥1.27T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥308.8bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥635m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥3.1bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥18.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.3bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥3.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥2.4bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥2.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.7bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥1.7bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥710.1bnat 2022-06-30Cons.Assets
Total assets¥702.4bnat 2022-03-31Cons.Assets
Total assets¥697.5bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥466.3bnat 2022-06-30Cons.Liabilities
Total liabilities¥461.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥243.7bnat 2022-06-30Cons.Net assets
Net assets / equity¥241.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥237.4bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥94.4bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥94.3bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥29.222022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥189.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥24.552021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥26.862022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥174.482021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥22.552021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio34.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.0%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥14.6bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥14.6bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥401m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue2022-04-01 → 2022-06-30¥22.2bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2022-04-01 → 2022-06-30¥22.2bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2022-04-01 → 2022-06-30¥133m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2022-04-01 → 2022-06-30¥612m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1.9bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2022-04-01 → 2022-06-30¥288m
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue2022-04-01 → 2022-06-30¥311.8bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue external2022-04-01 → 2022-06-30¥299.4bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥1.5bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥356m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥94m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥338.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥323.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥14.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥14.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥14.5bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥466m
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue2021-04-01 → 2021-06-30¥22.5bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2021-04-01 → 2021-06-30¥22.5bn
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥0
jpcrp040300-q1r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2021-04-01 → 2021-06-30¥350m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2021-04-01 → 2021-06-30¥403m
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1.5bn
jpcrp040300-q1r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2021-04-01 → 2021-06-30¥195m
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue2021-04-01 → 2021-06-30¥297.6bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue external2021-04-01 → 2021-06-30¥284.9bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥12.7bn
jpcrp040300-q1r_E02608-000Medical Products Retailreportable segmentsegment profit2021-04-01 → 2021-06-30¥554m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥1.3bn
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥966m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥305m
jpcrp040300-q1r_E02608-000Other Related Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥0
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥323.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥308.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥14.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 420
ItemContextValueUnit
Non operating incomePrior1YTDDuration1792000000JPY
Non operating incomeCurrentYTDDuration1918000000JPY
Interest expenses noePrior1YTDDuration18000000JPY
Interest expenses noeCurrentYTDDuration20000000JPY
Equity in losses of affiliates noePrior1YTDDuration8000000JPY
Equity in losses of affiliates noeCurrentYTDDuration67000000JPY
Rent expenses on real estates noePrior1YTDDuration47000000JPY
Rent expenses on real estates noeCurrentYTDDuration47000000JPY
Other noePrior1YTDDuration93000000JPY
Other noeCurrentYTDDuration37000000JPY
Non operating expensesPrior1YTDDuration168000000JPY
Non operating expensesCurrentYTDDuration172000000JPY
Ordinary incomePrior1YTDDuration2258000000JPY
Ordinary incomeCurrentYTDDuration3142000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration0JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration64000000JPY
Gain on sales of investment securities eiPrior1YTDDuration425000000JPY
Gain on sales of investment securities eiCurrentYTDDuration－JPY
Gain on liquidation of investment securities eiPrior1YTDDuration－JPY
Gain on liquidation of investment securities eiCurrentYTDDuration16000000JPY
Other eiPrior1YTDDuration0JPY
Other eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration426000000JPY
Extraordinary incomeCurrentYTDDuration80000000JPY
Loss on disposal of noncurrent assets elPrior1YTDDuration56000000JPY
Loss on disposal of noncurrent assets elCurrentYTDDuration6000000JPY
Impairment loss elPrior1YTDDuration6000000JPY
Impairment loss elCurrentYTDDuration19000000JPY
Loss on valuation of investment securities elPrior1YTDDuration231000000JPY
Loss on valuation of investment securities elCurrentYTDDuration169000000JPY
Other elPrior1YTDDuration0JPY
Other elCurrentYTDDuration3000000JPY
Extraordinary lossPrior1YTDDuration294000000JPY
Extraordinary lossCurrentYTDDuration200000000JPY
Income before income taxesPrior1YTDDuration2390000000JPY
Income before income taxesCurrentYTDDuration3023000000JPY
Income taxes currentPrior1YTDDuration1768000000JPY
Income taxes currentCurrentYTDDuration1799000000JPY
Income taxes deferredPrior1YTDDuration-1116000000JPY
Income taxes deferredCurrentYTDDuration-845000000JPY
Income taxesPrior1YTDDuration651000000JPY
Income taxesCurrentYTDDuration953000000JPY
Profit lossPrior1YTDDuration1738000000JPY
Profit lossCurrentYTDDuration2069000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration7000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration8000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration1730000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration2061000000JPY
Profit lossPrior1YTDDuration1738000000JPY
Profit lossCurrentYTDDuration2069000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass